Found 5 matching trials
Hib-MenCY-TT Vaccine Study Compared to Licensed Hib and Meningococcal Serogroup C Conjugate Vaccines PHASE2 This study is evaluating the safety and immunogenicity of Hib-MenCY-TT vacc...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Comparison of Safety and Immunogenicity of Pediacel™ and Infanrix™ IPV+Hib (Penta) Given in a 3 Dose Schedule in Infants PHASE3 Pediacel™ is currently licensed in the UK for use as a 3 dose regimen for t...
Show More Location
Multiple Locations
Learn More & Join Trial
Dose Ranging Study of Combined Haemophilus Influenzae Type B-Meningococcal Serogroups CY (Hib-MenCY-TT) Vaccine PHASE2 This study evaluated the safety and immunogenicity of 3 formulations of Hib...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Study to Evaluate GlaxoSmithKline (GSK) Biologicals' MenC-TT Vaccine and Hib-MenC-TT Vaccine in Infants PHASE2 The purpose of this primary vaccination study is to evaluate the immunogeni...
Show More Location
Multiple Locations
Learn More & Join Trial
3 Formulations of Hib-MenCY-TT Vaccine & 1 Formulation of Hib-MenC-TT Vaccine Compared to Licensed Meningococcal Serogroup C Conjugate Vaccine, Each Administered at 2,3,4 Mths of Age PHASE2 This study evaluated the safety and immunogenicity of 3 formulations of Hib...
Show More Location
GSK Investigational Site
Learn More & Join Trial